Active Ingredient History
Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma. As an immune suppressor it is used in nephrotic syndrome, granulomatosis with polyangiitis, and following organ transplant, among other conditions. It is taken by mouth or injection into a vein. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Anemia, Aplastic (Phase 3)
Anemia, Sickle Cell (Phase 2)
Graft vs Host Disease (Phase 2)
Hematologic Neoplasms (Phase 2)
Immunosuppression Therapy (Phase 2)
Leukemia, Myeloid, Acute (Phase 1)
Lymphoma, T-Cell, Peripheral (Phase 2)
Mucopolysaccharidoses (Phase 2/Phase 3)
Multiple Myeloma (Phase 1)
Myelodysplastic Syndromes (Phase 2)
Neutropenia (Phase 2)
Osteopetrosis (Phase 2/Phase 3)
Pancytopenia (Phase 2)
Thrombocytopenia (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
